These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10081818)

  • 21. Synthesis of new n-substituted cyclic imides with potential anxiolytic activity. XXIII. Derivatives of 2'-chlorodibenzo[e.h]bicyclo[2.2.2]octane-2,3-dicarboximide.
    Kossakowski J; Perliński M
    Acta Pol Pharm; 2002; 59(6):423-7. PubMed ID: 12669763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling.
    Barlocco D; Cignarella G; Tondi D; Vianello P; Villa S; Bartolini A; Ghelardini C; Galeotti N; Anderson DJ; Kuntzweiler TA; Colombo D; Toma L
    J Med Chem; 1998 Feb; 41(5):674-81. PubMed ID: 9513595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and analgesic activity of some 5-(4-hydroxyphenyl)-2-azabicyclo[3.2.1]octanes.
    Ong HH; Anderson VB; Wilker JC; Spaulding TC; Meyerson LR
    J Med Chem; 1980 Jul; 23(7):726-9. PubMed ID: 6249930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Total synthesis of (+/-)-13-methoxy-15-oxozoapatlin, a rearranged kaurane diterpenoid.
    Britton RA; Piers E; Patrick BO
    J Org Chem; 2004 Apr; 69(9):3068-75. PubMed ID: 15104445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kappa-receptor selective binding of opioid ligands with a heterocyclic bicyclo[3.3.1]nonan-9-one structure.
    Benyhe S; Márki A; Nachtsheim C; Holzgrabe U; Borsodi A
    Acta Biol Hung; 2003; 54(2):147-55. PubMed ID: 14535620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of 2-(pyridin-3-yl)-1-azabicyclo[3.2.2]nonane, 2-(pyridin-3-yl)-1-azabicyclo[2.2.2]octane, and 2-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, a class of potent nicotinic acetylcholine receptor-ligands.
    Bhatti BS; Strachan JP; Breining SR; Miller CH; Tahiri P; Crooks PA; Deo N; Day CS; Caldwell WS
    J Org Chem; 2008 May; 73(9):3497-507. PubMed ID: 18363376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of a novel series of (1'S,2R,4'S)-3H-4'-azaspiro[benzo[4,5]imidazo[2,1-b]oxazole-2,2'-bicyclo[2.2.2]octanes] with high affinity for the α7 neuronal nicotinic receptor.
    Cook J; Zusi FC; Hill MD; Fang H; Pearce B; Park H; Gallagher L; McDonald IM; Bristow L; Macor JE; Olson RE
    Bioorg Med Chem Lett; 2017 Nov; 27(22):5002-5005. PubMed ID: 29050783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of azabicyclo[3.2.1]octane derivatives as potent mixed vasopressin antagonists.
    Crombie AL; Antrilli TM; Campbell BA; Crandall DL; Failli AA; He Y; Kern JC; Moore WJ; Nogle LM; Trybulski EJ
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3742-5. PubMed ID: 20471258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A practical chemo-enzymatic synthesis of homochiral bicyclo[2.2.2]octane-2,5-dione.
    Luo Y; Carnell AJ
    J Org Chem; 2010 Mar; 75(6):2057-60. PubMed ID: 20151711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of novel diazatricyclodecanes (DTDs). Effects of structural variation at the C3' allyl end and at the phenyl ring of the cinnamyl chain on mu-receptor affinity and opioid antinociception.
    Pinna GA; Cignarella G; Ruiu S; Loriga G; Murineddu G; Villa S; Grella GE; Cossu G; Fratta W
    Bioorg Med Chem; 2003 Sep; 11(18):4015-26. PubMed ID: 12927864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor.
    Lu YF; Xu H; Liu-Chen LY; Chen C; Partilla JS; Brine GA; Carroll FI; Rice KC; Lai J; Porreca F; Sadee W; Rothman RB
    Synapse; 1998 Feb; 28(2):117-24. PubMed ID: 9450512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of the -CH2X substituent on the regioselectivity of intramolecular meta-photocycloaddition reactions.
    Wegmann M; Bach T
    J Org Chem; 2015 Feb; 80(3):2017-23. PubMed ID: 25587911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Facile domino access to chiral bicyclo[3.2.1]octanes and discovery of a new catalytic activation mode.
    Tan B; Lu Y; Zeng X; Chua PJ; Zhong G
    Org Lett; 2010 Jun; 12(12):2682-5. PubMed ID: 20469881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformationally constrained ethylenediamines: synthesis and receptor binding of 6,8-diazabicyclo[3.2.2]nonanes.
    Weigl M; Bedürftig S; Maier CA; Wünsch B
    Bioorg Med Chem; 2002 Jul; 10(7):2245-57. PubMed ID: 11983522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and structure-activity relationship of novel 1,4-diazabicyclo[2.2.2]octane derivatives as potent antimicrobial agents.
    Yarinich LA; Burakova EA; Zakharov BA; Boldyreva EV; Babkina IN; Tikunova NV; Silnikov VN
    Eur J Med Chem; 2015 May; 95():563-73. PubMed ID: 25867737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3,7-Diazabicyclane: a new narcotic analgesic.
    Salva PS; Hite GJ; Heyman RA; Gianutsos G
    J Med Chem; 1986 Oct; 29(10):2111-3. PubMed ID: 2876106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Base catalyzed synthesis of bicyclo[3.2.1]octane scaffolds.
    Boehringer R; Geoffroy P; Miesch M
    Org Biomol Chem; 2015 Jul; 13(25):6940-3. PubMed ID: 26053672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of new n-substituted cyclic imides with potential anxiolytic activity. XVIII. Derivatives of 1-bromo-dibenzo[e.h]bicyclo[2.2.2] octane-2.3-dicarboximide.
    Kossakowski J; Perliński M
    Acta Pol Pharm; 2001; 58(4):257-62. PubMed ID: 11693729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
    J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-affinity relationship studies on 5-HT1A receptor ligands. 1. Heterobicyclic phenylpiperazines with N4-alkyl substituents.
    van Steen BJ; van Wijngaarden I; Tulp MT; Soudijn W
    J Med Chem; 1993 Sep; 36(19):2751-60. PubMed ID: 8410989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.